Details for Patent: 8,193,229
✉ Email this page to a colleague
Summary for Patent: 8,193,229
Title: | Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors |
Abstract: | Disclosed are methods of treating a hyperproliferative disorder or a disease related to vasculogenesis or angiogenesis in a mammal, comprising administering to said mammal an effective amount of a compound of the formula ##STR00001## or a pharmaceutically accepted salt thereof, wherein A, R.sup.1, R.sup.2, R.sup.7, R.sup.8, and R.sup.9 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. |
Inventor(s): | Wallace; Eli M. (Boulder, CO), Lyssikatos; Joseph P. (Piedmont, CA), Marlow; Allison L. (Boulder, CO), Hurley; T. Brian (Boulder, CO) |
Assignee: | Array Biopharma Inc. (Boulder, CO) |
Application Number: | 12/824,521 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,193,229
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,193,229
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1482932 | ⤷ Sign Up | PA2019007 | Lithuania | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | LUC00100 | Luxembourg | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | 300974 | Netherlands | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | 2019C/510 | Belgium | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | CA 2019 00011 | Denmark | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | C20190010 00281 | Estonia | ⤷ Sign Up |
European Patent Office | 1482932 | ⤷ Sign Up | 14/2019 | Austria | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |